Viewing Study NCT02153632

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:41 PM
Ignite Modification Date: 2026-02-08 @ 4:51 AM
Study NCT ID: NCT02153632
Status: TERMINATED
Last Update Posted: 2022-02-16
First Post: 2014-05-30
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
Sponsor: Adamas Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Parkinson's Disease View
None Levodopa Induced Dyskinesia (LID) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Parkinson's Disease View
None Levodopa Induced Dyskinesia (LID) View
None LID View
None Parkinsonism View
None Dyskinesia View